NIMS Medical Genetics department in Hyderabad offers cutting-edge diagnostic and therapeutic services for rare genetic ...

Synthetic biology specialist Synlogic will start phase 3 testing of a drug for rare metabolic disorder phenylketonuria (PKU) next year, after reporting solid proof-of-concept data.

SEMINOLE, Fla. (WFLA) — A Pinellas County mother is in a desperate fight to keep her 4-year-old son healthy. Gideon Bennett ...

IN Jervis's introductory study, and in subsequent case reports of phenylketonuria (phenylpyruvic oligophrenia), a blonde hair colour and a fair skin have been noted in the large majority of the ...

A Seminole mom is fighting for her son's health after a rare disorder left him dependent on a strict medical diet. But now, ...

The biochemist introduced the first heel-prick tests for newborn babies in Spain, protecting infants from life-changing ...

A Pinellas County mother is in a desperate fight to keep her 4-year-old son healthy. Gideon Bennett has a rare genetic ...

BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) had its target price upped by UBS Group from $109.00 to $113.00 in a ...

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and ...

The Amsterdam-based company recently received IVDR certification for other tests including one for phenylketonuria.